Development of TP-317 for the Induction and Maintenance of Remission in Ulcerative Colitis Patients

Information

• Research Project
• 9592266

• ApplicationId

  9592266

• Core Project Number

  R44DK116460

• Full Project Number

  4R44DK116460-02

• Serial Number

  116460

• FOA Number

  PA-16-302

• Sub Project Id

• Project Start Date

  9/18/2017 - 7 years ago

• Project End Date

  2/29/2020 - 4 years ago

• Program Officer Name

  DENSMORE, CHRISTINE L

• Budget Start Date

  9/20/2018 - 6 years ago

• Budget End Date

  8/31/2019 - 5 years ago

• Fiscal Year

  2018

• Support Year

  02

• Suffix

• Award Notice Date

  9/14/2018 - 6 years ago

Organizations

• THETIS PHARMACEUTICALS, LLC

IC Name

• Activity

  R44

• Administering IC

  DK

• Application Type

  4

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  1396059

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  847

• Ed Inst. Type

• Funding ICs

  NIDDK:1396059\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  THETIS PHARMACEUTICALS, LLC

• Organization Department

• Organization DUNS

  068662462

• Organization City

  BRANFORD

• Organization State

  CT

• Organization Country

  UNITED STATES

• Organization Zip Code

  064052904

• Organization District

  UNITED STATES